Bio-Assistance
Your partner in new drug R&D
R&D Lab

About us

Since its creation in 1999, Bio-Assistance has been led by Hanna Sikorska, Ph.D., a drug product development professional with experience in developing probiotics, peptide, monoclonal antibody and small molecule-derived medicinal products for oral, topical, intravenous and inhalational administration in the treatment of endocrine disorders, respiratory tract diseases, cancer, pain management and cardiovascular radionuclide diagnostic imaging.

Hanna Sikorska worked for many years as a Vice-President, Chief Scientific Officer, for Akela Pharma Inc., LAB Development Inc., and Rougier Biotech Ltd. in Montreal, Canada and participated in the development of many successful drug candidates from the in-vitro proof-of-concept to Phase 3 clinical studies. She organized and took part in several meetings with regulatory agencies in Europe, Canada, and the USA. She has been involved in the design, construction and qualification of clean rooms for fermentation, downstream purification and parenteral formulation of murine monoclonal antibodies in compliance with Good Manufacturing Practice (GMP).

She has developed and manufactured several monoclonal antibodies to a variety of clinically useful antigens in the treatment, diagnosis, and research of cancer, bacterial infections and coronary artery diseases.